C4 Therapeutics, Inc. - Common Stock (NQ:CCCC)
Headline News about C4 Therapeutics, Inc. - Common Stock

Via Benzinga

Via Benzinga


Key Takeaways From C4 Therapeutics Analyst Ratings
May 09, 2024
Via Benzinga

Breaking Down C4 Therapeutics: 4 Analysts Share Their Views
February 26, 2024
Via Benzinga




Analyst Expectations For C4 Therapeutics's Future
January 29, 2024
Via Benzinga




12 Health Care Stocks Moving In Friday's Pre-Market Session
December 15, 2023
Via Benzinga

Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
December 13, 2023


12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via Benzinga


US Stocks Mixed; Producer Prices Unchanged For November
December 13, 2023


12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 13, 2023
Via Benzinga


Via Benzinga




12 Health Care Stocks Moving In Tuesday's Intraday Session
December 12, 2023
Via Benzinga

Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results
December 12, 2023

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.